NFE2L2 and Hepatic fibrosis: These results suggested that the therapeutic effect of SIL-loaded NPs against liver fibrosis may be through high activation of the Nrf2 content to inhibit oxidative stress-mediated hepatocyte damage in the rat liver fibrosis model.